Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
-0.29%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$9.57B
AUM Growth
-$135M
(-1.4%)
Cap. Flow
-$60.4M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
17.19%
Holding
1,945
New
104
Increased
419
Reduced
879
Closed
82
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$50.2M |
| 2 |
American Tower
AMT
|
+$7.36M |
| 3 |
NVIDIA
NVDA
|
+$5.82M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$5.02M |
| 5 |
NXP Semiconductors
NXPI
|
+$4.47M |
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$32.7M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$16.7M |
| 3 |
Microsoft
MSFT
|
+$7.31M |
| 4 |
Apple
AAPL
|
+$4.26M |
| 5 |
Equity Residential
EQR
|
+$4.15M |
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Financials | 15.77% |
| 3 | Healthcare | 13.04% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Kadant
KAI
$3.76B
| $208K | ﹤0.01% |
2,200
| – | – |
|
1227
Standard BioTools
LAB
$493M
| $207K | ﹤0.01% |
31,600
+8,400
| +36% | +$55K |
|
|
MACK
1228
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $207K | ﹤0.01% |
26,183
+18,811
| +255% | +$149K |
|
|
ACRE
1229
Ares Commercial Real Estate
ACRE
$270M
| $205K | ﹤0.01% |
16,580
+10,400
| +168% | +$129K |
|
1230
TruBridge
TBRG
$299M
| $205K | ﹤0.01% |
6,900
+720
| +12% | +$21.4K |
|
1231
Genpact
G
$7.53B
| $204K | ﹤0.01% |
6,500
| – | – |
|
1232
Super Micro Computer
SMCI
$26.9B
| $204K | ﹤0.01% |
120,000
| – | – |
|
|
BBBY
1233
DELISTED
Bed Bath & Beyond Inc
BBBY
| $204K | ﹤0.01% |
9,700
-5,000
| -34% | -$105K |
|
|
VIVO
1234
DELISTED
Meridian Bioscience Inc
VIVO
| $204K | ﹤0.01% |
14,520
+1,500
| +12% | +$21.1K |
|
1235
ATN International
ATNI
$239M
| $203K | ﹤0.01% |
3,400
| – | – |
|
|
VRE
1236
Veris Residential
VRE
$1.51B
| $202K | ﹤0.01% |
12,100
-12,800
| -51% | -$214K |
|
1237
Nordic American Tanker
NAT
$680M
| $201K | ﹤0.01% |
96,000
+85,900
| +850% | +$180K |
|
1238
PTC Therapeutics
PTCT
$4.68B
| $201K | ﹤0.01% |
7,800
-2,200
| -22% | -$56.7K |
|
1239
Freshpet
FRPT
$2.61B
| $200K | ﹤0.01% |
10,000
| – | – |
|
1240
Hancock Whitney
HWC
$5.38B
| $199K | ﹤0.01% |
3,850
+150
| +4% | +$7.75K |
|
|
UHT
1241
Universal Health Realty Income Trust
UHT
$569M
| $198K | ﹤0.01% |
3,300
| – | – |
|
|
ANH
1242
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $197K | ﹤0.01% |
43,300
| – | – |
|
1243
CorVel
CRVL
$4.54B
| $196K | ﹤0.01% |
12,000
| – | – |
|
|
MDRX
1244
DELISTED
Veradigm Inc. Common Stock
MDRX
| $195K | ﹤0.01% |
15,800
+800
| +5% | +$9.87K |
|
1245
Banner Corp
BANR
$2.32B
| $194K | ﹤0.01% |
3,500
-3,270
| -48% | -$181K |
|
1246
Voyager Therapeutics
VYGR
$227M
| $194K | ﹤0.01% |
10,300
| – | – |
|
1247
ANI Pharmaceuticals
ANIP
$2.13B
| $192K | ﹤0.01% |
3,010
-100
| -3% | -$6.38K |
|
1248
S&T Bancorp
STBA
$1.49B
| $192K | ﹤0.01% |
4,800
| – | – |
|
1249
Coca-Cola Consolidated
COKE
$10.5B
| $191K | ﹤0.01% |
10,250
+250
| +3% | +$4.66K |
|
1250
Par Pacific Holdings
PARR
$1.81B
| $189K | ﹤0.01% |
11,100
-7,500
| -40% | -$128K |
|